Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

94.15 -25.07 (-21.03%)
Streaming Delayed Price Updated: 1:35 PM EDT, Aug 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna Inc

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
99 100 Next >
Moderna, BioNTech And Other Big Stocks Moving Higher On Monday
U.S. stocks traded mixed, with the Dow Jones falling around 150 points on Monday. Here are some big stocks recording gains in today’s session. Genelux Corporation (NASDAQ: GNLX) gained 19.2% to $28.58.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Will The Bears Deliver The Knockout? Prepare For The Upcoming Week With Mando Trading!
$SPY (ARCA: SPY) Have lows been put in or is there more to go? Slow start to the week In terms of data, but a big finish with Jackson Hole starting Thursday and Powell on Friday. This event crushed the... 
Via Benzinga
SpaceX On Par With Intel, Disney; US Weight Loss Drugs Pricier; Moderna, Pfizer's Shot Effective Against New Variant: Today's Top Stories
Benzinga 
Via Benzinga
MRNA Stock Alert: Why Is Moderna Up 7% Today?
Investors in Moderna (MRNA) stock have received a boost today from reports that a late summer Covid wave could be on the horizon. 
Via InvestorPlace
Exposures COVID-19
Moderna Inc. (NASDAQ: MRNA) is a Leading Gainer in 8/17 Morning Trading
Via Investor Brand Network
$1000 Invested In This Stock 5 Years Ago Would Be Worth $5,300 Today
Via Benzinga
Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance
The companies are hoping to launch their updated Covid shots in September. 
Via Investor's Business Daily
Exposures COVID-19
2 Biotech Stocks That Could Make You Richer
Neither is performing particularly well this year compared to the broader market, but don't let that chase you away. 
Via The Motley Fool
Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies
Moderna Inc (NASDAQ: MRNA) announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralizing antibodies... 
Via Benzinga
Exposures COVID-19
Moderna Clinical Trial Data Confirm Its Updated COVID-19 Vaccine Generates Robust Immune Response in Humans Against Widely Circulating Variants
Via ACCESSWIRE
Cheaper Alternatives of Weight-Loss Drugs? Chinese Pharma Companies Are Working On a Local Version
Chinese pharma firms are reportedly working on producing local equivalents of advanced weight-loss medications, challenging Western pharmaceutical giants in a  
Via Benzinga
Moderna Unusual Options Activity
Via Benzinga
Looking At Moderna's Recent Unusual Options Activity
Via Benzinga
Why Moderna Stock Sunk Today
Moderna, Inc. (NASDAQ: MRNA) shares are trading lower on Monday. 
Via Benzinga
Your Mid-August Market Update: Selling And Scanning
Stock indexes slid 1% today with bonds closing weaker, down at 2023 lows as interest rates traded up to highs in 2023. 
Via Talk Markets
Topics Bonds
Exposures Debt Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Pharma Stocks to Sell in August Before They Crash and Burn
Stay far away from these pharma stocks that are suffering from declining sales and weak pipelines of future products. 
Via InvestorPlace
Buy Merck (MRK) Stock Now to Ride a Wave Higher in Healthcare
Healthcare stocks are starting to shine in 2023 after bottoming out and MRK stock is particularly appealing. Here's why. 
Via InvestorPlace
Meet Eris, The COVID Variant Behind A Summer Resurgence In Cases: 3 Drugmakers Prep Fall Booster Shots
Via Benzinga
Exposures COVID-19
Moderna (MRNA) Q2 2023 Earnings Call Transcript
MRNA earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Moderna Sees 2023 Covid Vaccine Sales In Back Half Of The Year
The game's not over for Moderna. The company says most of its sales are yet to come. 
Via Investor's Business Daily
Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates
Via ACCESSWIRE
The 3 Best Healthcare Stocks to Buy in August
Healthcare is always the answer in the face of volatility. Here are the three best healthcare stocks to buy in the sector. 
Via InvestorPlace
3 Healthcare Stocks to Sell in August Before They Crash and Burn
Steer clear of these healthcare stocks, each of which is struggling with significant problems that are impacting their earnings. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 73 companies reached new 52-week lows. 
Via Benzinga
Moderna Lifts 2023 COVID-19 Vaccine Sales Outlook, Despite Over 90% Fall In Q2 Sales
Moderna Inc (NASDAQ: MRNA) shares are trading higher after the company reported a smaller-than-expected Q2 loss of $(3.62), beating  
Via Benzinga
Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.
The company hopes to launch an updated Covid booster shot this fall. But there are several complications. 
Via Investor's Business Daily
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
Stocks appear to be entrenched in an August swoon and it remains to be seen if big tech earnings provide a boost. 
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.